ADARx Pharmaceuticals, Inc. (ADRX)

CIK 1802369 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ADARx Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Oct 16, 2026SCHEDULE 13G0001764435-26-000003
Oct 5, 2026SCHEDULE 13D0001072613-26-000820
Oct 2, 2026SCHEDULE 13D0000947871-26-000917
Oct 1, 2026SCHEDULE 13G0001193125-26-410626
Sep 30, 202640000947871-26-000911
Sep 30, 202640000947871-26-000910
Sep 30, 202640000947871-26-000912
Sep 29, 202640001193125-26-408064
Sep 29, 202640001231919-26-001406
Sep 29, 202640001193125-26-408061
Sep 28, 2026424B40001193125-26-403094
Sep 28, 20268-K0001193125-26-405297
Sep 28, 2026S-80001193125-26-405447
Sep 28, 202640001729510-26-000006
Sep 28, 202640002153958-26-000004
Sep 28, 202640002153534-26-000004
Sep 28, 202640002154450-26-000004
Sep 28, 202640002151480-26-000004
Sep 24, 2026EFFECT9999999995-26-003052
Sep 24, 2026CERT0001354457-26-000906
Sep 24, 2026S-1MEF0001193125-26-401133
Sep 24, 202630001706399-26-000002
Sep 24, 202630001729510-26-000004
Sep 24, 202630001323304-26-000004
Sep 24, 202630001282930-26-000014